Portal hypertension: from pathophysiology to clinical practice
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Portal hypertension (PHT) is responsible for the more severe and often lethal complications of cirrhosis such as bleeding oesophageal varices, ascites, renal dysfunction and hepatic encephalopathy. Because of the combined impact of these complications, PHT remains the most important cause of morbidity and mortality in patients with cirrhosis. Over the years, it has become clear that a decrease in portal pressure is not only protective against the risk of variceal (re)bleeding but is also associated with a lower long‐term risk of developing complications and an improved long‐term survival. A milestone in therapy was the introduction of non‐selective β‐blockers for the prevention of bleeding and rebleeding of gastro‐esophageal varices. However, in practice, less than half the patients under β‐blockade are protected from these risks, supporting the overall demand for innovation and expansion of our therapeutic armamentarium. Recent advances in the knowledge of the pathophysiology of cirrhotic PHT have directed future therapy towards the increased intrahepatic vascular resistance, which, in part, is determined by an increased hepatic vascular tone. This increased vasculogenic component provides the rationale for the potential use of therapies aimed at increasing intrahepatic vasorelaxing capacity via gene therapy, liver‐selective nitric oxide donors and statines on the one hand, and at antagonizing excessive intrahepatic vasoconstrictor force through the use of endothelin antagonists, angiotensin blockers, α 1 adrenergic antagonists or combined α 1‐ and non‐selective β‐blockers or somatostatin analogues on the other. The focus of this review is to give an update on the pathophysiology of PHT in order to elucidate these potential novel strategies subsequently.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications
Maines, M. D. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.10.3290025 · Cited by 1,707 · cited 1×
“, and HO-2, which is thought to constitute the major enzyme activity in the liver parenchyma (44).”
BackgroundGonzález-Abraldes, J., Albillos, A., Bañares, R., Del Arbol, L. R., Moitinho, E., Rodríguez, C., González, M., Escorsell, A., García-Pagán, J. C., & Bosch, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.26288 · Cited by 165
Review article: volume expansion in patients with cirrhosis
Henriksen, J. H., Kiszka‐Kanowitz, M., Bendtsen, F., & Møller, S. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.16.s5.3.x · Cited by 46 · cited 1×
“This diversity in vascular reactions within one cirrhotic patient may either be owing to locally increasing levels of endogenous vasoconstrictors compared with the vasodilators, relative ‘underfilling’ of the vasodilated systemic circulation or a change in vascular reactivity (74, 75).”
Background
Cited by
Cancer and liver cirrhosis: implications on prognosis and management
Pinter, M., Trauner, M., Peck-Radosavljevic, M., & Sieghart, W. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000042 · Cited by 295
Laleman, W., Simon-Talero, M., Maleux, G., Perez, M., Ameloot, K., Soriano, G., Villalba, J., Garcia-Pagan, J.-C., Barrufet, M., Jalan, R., et al. (2013) · Hepatology · doi:10.1002/hep.26314 · Cited by 277
Self-citationCirrhotic cardiomyopathy: pathogenesis and clinical relevance
Wiese, S., Hove, J. D., Bendtsen, F., & Møller, S. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.210 · Cited by 267
Verbeke, L., Farre, R., Trebicka, J., Komuta, M., Roskams, T., Klein, S., Elst, I. V., Windmolders, P., Vanuytsel, T., Nevens, F., et al. (2014) · Hepatology · doi:10.1002/hep.26939 · Cited by 258
Self-citationEarly features of acute-on-chronic alcoholic liver failure: a prospective cohort study
Katoonizadeh, A., Laleman, W., Verslype, C., Wilmer, A., Maleux, G., Roskams, T., & Nevens, F. (2010) · Gut · doi:10.1136/gut.2009.189639 · Cited by 252
Self-citation
Metadata
- Authors
- Laleman, W., Van Landeghem, L., Wilmer, A., Fevery, J., & Nevens, F.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2005-11-11
- Volume
- 25
- Issue
- 6
- Pages
- 1079-1090
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W2062818431
- Cited by
- 132
- References
- 3
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Portal hypertension: from pathophysiology to clinical practice. https://app.cochat.ai/papers/10.1111/j.1478-3231.2005.01163.x
- The paper
- Laleman, W., Van Landeghem, L., Wilmer, A., Fevery, J., & Nevens, F. (2005). Portal hypertension: from pathophysiology to clinical practice. Liver International. https://doi.org/10.1111/j.1478-3231.2005.01163.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.